Full Press Release Details
Immutep Presents Positive Interim Data from Phase II TACTI-002 Trial at SITC.
IMMP
Immutep Presents Positive Interim Data from Phase II TACTI-002 Trial at SITC
Key Takeaway: Immutep Presents Positive Interim Data from Phase II TACTI-002 Trial at SITC